Literature DB >> 12458989

Advising patients who seek complementary and alternative medical therapies for cancer.

Wendy A Weiger1, Michael Smith, Heather Boon, Mary Ann Richardson, Ted J Kaptchuk, David M Eisenberg.   

Abstract

Many patients with cancer use complementary and alternative medical (CAM) therapies. Physicians need authoritative information on CAM therapies to responsibly advise patients who seek these interventions. This article summarizes current evidence on the efficacy and safety of selected CAM therapies that are commonly used by patients with cancer. The following major categories of interventions are covered: dietary modification and supplementation, herbal products and other biological agents, acupuncture, massage, exercise, and psychological and mind-body therapies. Two categories of evidence on efficacy are considered: possible effects on disease progression and survival and possible palliative effects. In evaluating evidence on safety, two types of risk are considered: the risk for direct adverse effects and the risk for interactions with conventional treatments. For each therapy, the current balance of evidence on efficacy and safety points to whether the therapy may be reasonably recommended, accepted (for example, dietary fat reduction in well-nourished patients with breast or prostate cancer), or discouraged (for example, high-dose vitamin A supplementation). This strategy allows the development of an approach for providing responsible, evidence-based, patient-centered advice to persons with cancer who seek CAM therapies.

Entities:  

Mesh:

Year:  2002        PMID: 12458989     DOI: 10.7326/0003-4819-137-11-200212030-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  46 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

2.  Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.

Authors:  Danielle N Margalit; Julie L Kasperzyk; Neil E Martin; Howard D Sesso; John Michael Gaziano; Jing Ma; Meir J Stampfer; Lorelei A Mucci
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-11       Impact factor: 7.038

3.  Natural products for cancer prevention.

Authors:  Heather Greenlee
Journal:  Semin Oncol Nurs       Date:  2012-02       Impact factor: 2.315

4.  Biologically based complementary and alternative medicine use among breast cancer survivors: relationship to dietary fat consumption and exercise.

Authors:  Mary C Politi; Carolyn Rabin; Bernardine Pinto
Journal:  Support Care Cancer       Date:  2006-04-19       Impact factor: 3.603

Review 5.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

Review 6.  Effects of complementary and integrative medicine on cancer survivorship.

Authors:  Moshe Frenkel; Victor Sierpina; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

7.  Insurance coverage and subsequent utilization of complementary and alternative medicine providers.

Authors:  William E Lafferty; Patrick T Tyree; Allen S Bellas; Carolyn A Watts; Bonnie K Lind; Karen J Sherman; Daniel C Cherkin; David E Grembowski
Journal:  Am J Manag Care       Date:  2006-07       Impact factor: 2.229

8.  Patient-physician communication about complementary and alternative medicine in a radiation oncology setting.

Authors:  Jin Ge; Jessica Fishman; Neha Vapiwala; Susan Q Li; Krupali Desai; Sharon X Xie; Jun J Mao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-03       Impact factor: 7.038

9.  Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients.

Authors:  Colin Schieman; Luke R Rudmik; Elijah Dixon; Francis Sutherland; Oliver F Bathe
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

10.  Opinions on chelation therapy in patients undergoing coronary angiography: cross-sectional survey.

Authors:  Hude Quan; P Diane Galbraith; Colleen M Norris; Danielle A Southern; Kathryn King; Marja J Verhoef; Marril L Knudtson; William A Ghali
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.